Matches in Nanopublications for { ?s ?p "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP379291.RAcFzXgRR2voUKIqjL3HUGRuw6vRZntznGVdFVlkNWfVY130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379291.RAcFzXgRR2voUKIqjL3HUGRuw6vRZntznGVdFVlkNWfVY130_provenance.
- NP379514.RAUglRzI4NIrFTFX8b32V7GBKDKdto90zX_W3bRRKiEW4130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379514.RAUglRzI4NIrFTFX8b32V7GBKDKdto90zX_W3bRRKiEW4130_provenance.
- NP411121.RAQn913r3IrbW2GeHY9Weoe92KypgelzP75V7UAScNGn4130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411121.RAQn913r3IrbW2GeHY9Weoe92KypgelzP75V7UAScNGn4130_provenance.
- NP379400.RApcLXAAoZkVXWUFNKHHuiZizZFXuPXlSmpegboXcx29U130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379400.RApcLXAAoZkVXWUFNKHHuiZizZFXuPXlSmpegboXcx29U130_provenance.
- NP411116.RAuUWWQC8NvHurgeXpuagDuJB0daJTFVzSRzDDhro-wog130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411116.RAuUWWQC8NvHurgeXpuagDuJB0daJTFVzSRzDDhro-wog130_provenance.
- NP411119.RAv1a7J_gjIsbSnv_mH7ow69E07PEJnVRTKEi7J9RtpzA130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411119.RAv1a7J_gjIsbSnv_mH7ow69E07PEJnVRTKEi7J9RtpzA130_provenance.
- NP379369.RAwTP9LdMekC1jHTYPhcr1bJ_OKDRQ7249BaAkS0rHGrU130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379369.RAwTP9LdMekC1jHTYPhcr1bJ_OKDRQ7249BaAkS0rHGrU130_provenance.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.